Evidence map›Paper›PMID 37673885›Full record

ArticleNature communications2023

Author Correction: A method for Boolean analysis of protein interactions at a molecular level.

Doroteya Raykova, Despoina Kermpatsou, Tony Malmqvist, Philip J Harrison, Marie Rubin Sander, Christiane Stiller, Johan Heldin, Mattias Leino, Sara Ricardo, Anna Klemm and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Doroteya Raykova *Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden. doroteya.raykova@farmbio.uu.se.ORCID http://orcid.org/0000-0001-6452-2199
Despoina Kermpatsou *Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-5872-4472
Tony MalmqvistAtlas Antibodies AB, Bromma, Sweden.ORCID http://orcid.org/0000-0003-0609-2009
Philip J HarrisonDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.
Marie Rubin SanderDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-9783-5682
Christiane StillerDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-6552-8426
Johan HeldinDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-0915-5303
Mattias LeinoDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.
Sara RicardoFaculty of Medicine, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0003-4091-2226
Anna KlemmVi2, Department of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-3466-1320
Leonor DavidFaculty of Medicine, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0003-4207-9258
Ola SpjuthDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-8083-2864
Kalyani VemuriDepartment of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-2544-5412
Anna DimbergDepartment of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-4422-9125
Anders SundqvistDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.
Maria NorlinDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-4348-6269
Axel KlaessonDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden.
Caroline KampfAtlas Antibodies AB, Bromma, Sweden.
Ola SöderbergDepartment of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical Center, SE-751 24, Uppsala, Sweden. ola.soderberg@farmbio.uu.se.ORCID http://orcid.org/0000-0003-2883-1925

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37673885
PMCPMC10482831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.